Artivion Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-06-14
Share capital
5,500,000.00 PLN
Activity description

Artivion Polska develops technologies for cardiac and vascular surgeons treating aortic diseases. Its products include the AMDS Hybrid Prosthesis, used to treat acute DeBakey Type I aortic dissections.

Registered address
ul. Józefa Piusa Dziekońskiego 1, 00-728 Warszawa, Poland
Website
artivion.com
Phone
Social media
Electronic delivery address
AE:PL-49131-93988-UWHHU-23

Financials

Revenue history (in m)

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Filing timeliness

Financial statements were filed on time, on average 44 days early. All were audited by a statutory auditor.

  • 202518/05/2026
  • 202425/06/2025
  • 202328/06/2024
  • 202229/06/2023
  • 202127/06/2022
  • 202002/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 12.15mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 422.23kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 11.03mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 8.34mMedianUSD 608.93kAverageUSD 11.85m

Industry

Offer

  • Aortic prostheses
  • Heart valves
  • Tissue allografts
  • Surgical sealants
  • Vascular patches
Certifications: ISO 13485

Website technology

Website
  • WordPress
Analytics and marketing
  • Google Tag Manager

Public procurement

133 tenders recorded as contractor: 21 national ($1,603,822) and 112 EU ($56,100,894).

SubjectAmount
Supply of single-use medical devices for the operating theatre and neurosurgical procedures and operations
$19,246
Purchase and successive supply of stent grafts with accessories
$140.9K
Supply of stents. Lot 1 – Custom-made hybrid system. Lot 2 – External support for venous grafts in coronary artery bypass surgery
$372.8K

Authorized Representatives

Dorota Izabela Farkas – President of the Management Board
Werner Karl Will – Management Board Member

Manner of representation

In the case of a multi-member management board, the company is represented by the President of the Management Board independently, or by the two remaining members of the management board jointly, or by one of the remaining members of the management board jointly with one commercial proxy. If only one member of the management board is appointed, that member represents the company independently.

Ownership

OwnerSharesShare valueStake
Cryolife Germany Holdco Gmbh
55,000$1,485,683.41100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2011-06-30.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $441,830.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$14,585
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$398.9K
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$14,350

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Arcon Polskasp. z o.o.
Consultronixsp. z o.o.
Novamed.PlS.A.
Medicavera Dahlhausen Groupsp. z o.o.
Biotechsp. z o.o.
Biochem PolskaS.A.
Mindray Medical Polandsp. z o.o.
Aqvitox Polskasp. z o.o.
Investmed-Investcars-Adamskisp. k.
Innovarissp. z o.o.

Change history

DateEvent
2023-04-13Name change
2022-09-13Address change
2019-04-03Address change
2015-07-22Share capital increase
2014-08-12Share capital increase

FAQ

Last updated: 2026-10-07